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the current-driven temperature controller. No field size 
dependence was observed down to 2 x 2 cm². 
 
 
 
Conclusion: This work demonstrates the feasibility of using 
an ion chamber-sized calorimeter as a practical means of 
measuring absolute dose to water in the radiotherapy clinic. 
The potential introduction of calorimetry into the clinical 
setting is significant as this fundamental technique has 
formed the basis of absorbed dose standards in many 
countries for decades. Considered as the most direct means 
of measuring dose, a “calorimeter for the people” could play 
an important role in solving the major challenges of 
contemporary dosimetry. In particular, investigations into the 
use of the GPC for MR-linac dosimetry are currently 
underway. 
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Purpose or Objective: Build-up material is commonly used in 
electron beam radiation therapy to overcome the skin sparing 
effect and to homogenise the dose distribution in case of 
irregular skin surfaces. Often, an individualised bolus is 
necessary. This process is complex and highly labour-
intensive, while adaptation of the bolus is time consuming. 
We implemented a new clinical workflow in which the bolus 
is designed on the CT scan in the treatment planning system 
(TPS). Subsequently a cast with the bolus shape is 3D-printed 
and filled with silicone rubber to create the bolus itself [1]. 
 
Material and Methods: In the new workflow (figure 1), a 
patient-specific bolus is designed in the TPS. A 2 mm 
expansion is used to create a cast around the bolus. 
Subsequently, this cast is smoothed to remove CT scan 
resolution effects. After conversion to a stereolithography 
file, the cast is printed in polylactic acid (PLA) with a 
filament printer and filled with silicone rubber. After removal 
of the PLA cast, the bolus is ready for clinical use. 
Before clinical implementation we performed a planning 
study with 11 patients to evaluate the difference in tumour 
coverage with a 3D-print bolus in comparison to the clinically 
delivered plan with a manually created bolus.  
During clinical implementation of the 3D-print workflow, for 
7 patients a second CT-scan with the 3D-print bolus in 
position was made to assess its geometrical accuracy and the 
resulting dose distribution. 
 
Results: The planning study showed at least equal coverage 
of GTV and CTV: V95% of the GTV was on average 97% (3D-
print) vs 84% (conventional). V85% of the CTV was on average 
97% (3D-print) vs 88% (conventional).  
Geometric comparison of the 3D-print bolus to the originally 
contoured bolus showed a high similarity (mean dice 
similarity coefficient of 0.87 (range 0.81 to 0.95).  
Comparison of the dose distributions at the planning CT scan 
to dose distributions at the second CT scan with the 3D print 
bolus in position showed only small differences (median 
difference in V95% GTV and V85% CTV of 0% (interquartile 
range: -12% to 0%) and -1.6% (interquartile range: -3.8 to 
0.5%), respectively).  
Time efficiency of the 3D-print workflow is likely to increase 
in comparison to the conventional workflow, with one less 
patient visit, and up to 3 hours less mould room time. 
 
Conclusion: The implemented workflow is feasible, patient 
friendly, safe, and results in high quality dose distributions. 
This new technique increases time efficiency and logistically 
aligns electron with photon external beam treatments.  
 
 
 
Figure 1: Illustration of the clinically implemented 3D-print 
workflow with designed bolus(A) and cast around the bolus(B) 
at the planning CT scan, smoothed cast (C), 3D model of the 
cast (D), printed cast (E) and silicone rubber final bolus (F).  
1. Holtzer, N.A., et al., 3D printing of tissue equivalent 
boluses and molds for external beam radiotherapy, Estro 33. 
2014: Vienna. 
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Radiation oncology is a rapidly evolving profession requiring 
continuous learning on the top of all routine activities. 
Residency is a unique period in a professional life where the 
main objective is to learn. Residency is full of research and 
educational opportunities for young radiation oncologists to 
gain know-how and expertise in clinical practice, patient 
care, fundamental, translational and/or clinical research and 
innovative technologies in the various aspects of our 
specialty. Through local, national and international 
programs, trainees gain valuable clinical and research 
experience and skills during and rapidly get the opportunity 
to disseminate information and update colleagues in their 
home institution. Playing a proactive role in the training will 
not only give access to the best training opportunities but 
will motivate as well supervisors in supporting trainee’s 
career development. 
In a competitive world with limited resources, building up 
good curriculum vitae with a number of publications and 
presentations is a major advantage that should be 
